Navigation Links
Roche Announces Significant Price Reduction of Two ACCU-CHEK(R) Glucose Monitoring Kits to Help Customers With Diabetes During These Difficult Economic Times
Date:2/6/2009

sulin delivery. The ACCU-CHEK brand encompasses blood glucose meters, infusion pumps, lancing and data management systems.

For more information, please visit www.accu-chek.com.

About Roche

Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As the world's largest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the Roche Group contributes on a broad range of fronts to improving people's health and quality of life. Roche is the world leader in in vitro diagnostics and drugs for cancer and transplantation as well as a market leader in virology. It is also active in other major therapeutic areas, such as autoimmune diseases, inflammatory and metabolic disorders and diseases of the central nervous system. In 2007, sales by the Pharmaceuticals Division totaled 36.8 billion Swiss francs, and the Diagnostics Division posted sales of 9.3 billion francs. Roche has R&D agreements and strategic alliances with numerous partners-including majority ownership interests in Genentech and Chugai-and has invested over 8 billion Swiss francs in R&D in 2007. Worldwide, Roche employs about 79,000 people. Additional information is available on the Internet at www.roche-diagnostics.us.

    For further information, please contact:
    Julie Vincent
    Public Relations Manager
    ACCU-CHEK(R) Brand
    julie.vincent@roche.com
    317-521-1910

'/>"/>
SOURCE Roche
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Rochester Medical Reports First Quarter Results
2. Rochester study raises new questions about controversial plastics chemical
3. University Medical Pharmaceuticals Appoints Tom Roche as Senior Vice President, Global Sales and Marketing
4. Rochester Medical Announces First Quarter 2009 Earnings Conference Call February 2, 2009
5. Rochester Medical Announces Settlement With TYCO Healthcare Group, L.P., Now Operating as Covidien Ltd.
6. Growth Opportunities for Actemra Will Propel Roche to Sixth Position in the Rheumatoid Arthritis Market by 2012
7. Roche Offers Fun Experience with ACCU-CHEK(R) Aviva Through New Rock My Meter Website
8. Fujirebio Diagnostics and Roche Diagnostics Sign Agreement for New Ovarian Cancer Test
9. Enigma Diagnostics Announces a Signed Term Sheet for Patent Licenses with Roche Molecular Systems, Inc.
10. Rochester Shoulder Surgeon Blends Innovative Techniques with Personalized Patient Care
11. New Roche Dual Target HIV-1 Test Approved for Use in European Union
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Medifast, Inc. to Announce Fourth Quarter and Fiscal Year-End Results on Wednesday, March 12, 2008 2Health News:Health groups issue updated colorectal cancer screening guidelines 2Health News:Health groups issue updated colorectal cancer screening guidelines 3Health News:New technique takes a big step in examination of small structures 2Health News:New technique takes a big step in examination of small structures 3Health News:New technique takes a big step in examination of small structures 4Health News:Parker Waichman Alonso LLP Files Suit Against General Electric Company on Behalf of a Man Who Developed Nephrogenic Systemic Fibrosis (NSF) from Contrast Agent Omniscan 2Health News:Parker Waichman Alonso LLP Files Suit Against General Electric Company on Behalf of a Man Who Developed Nephrogenic Systemic Fibrosis (NSF) from Contrast Agent Omniscan 3Health News:Community & Mission Hospital of Huntington Park Shutting Down Mission Campus, Terminating Workers 2Health News:New revelations in epigenetic control shed light on breast cancer 2
Breaking Medicine Technology:PRA International Hosts an Infectious Diseases Audio Conference 2PRA International Hosts an Infectious Diseases Audio Conference 3Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3FDA Launches Orphan Drug Workshop at KGI 2Nuvilex Renews MedX Master Distribution Agreement and Implements New Pricing for Talsyn Scar Cream 49191 1Nuvilex Renews MedX Master Distribution Agreement and Implements New Pricing for Talsyn Scar Cream 49191 2Nuvilex Renews MedX Master Distribution Agreement and Implements New Pricing for Talsyn Scar Cream 49191 3Prostate Cancer Patient Receives First RapidArc Radiotherapy Treatment at Major Danish Hospital 49187 1Prostate Cancer Patient Receives First RapidArc Radiotherapy Treatment at Major Danish Hospital 49187 2Prostate Cancer Patient Receives First RapidArc Radiotherapy Treatment at Major Danish Hospital 49187 3Arena Pharmaceuticals to Receive 24100 Million from Deerfield Management 49183 1Arena Pharmaceuticals to Receive 24100 Million from Deerfield Management 49183 2Arena Pharmaceuticals to Receive 24100 Million from Deerfield Management 49183 3Arena Pharmaceuticals to Receive 24100 Million from Deerfield Management 49183 4